Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps

A. Leader*, H. ten Cate, G. Spectre, E. A. M. Beckers, A. Falanga

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)76-88
Number of pages13
JournalCritical Reviews in Oncology/Hematology
Volume132
DOIs
Publication statusPublished - Dec 2018

Keywords

  • Anticoagulants
  • Arterial thrombosis
  • Bleeding
  • Neoplasms
  • Platelet aggregation inhibitors
  • Platelet transfusion
  • Thrombocytopenia
  • Venous thromboembolism
  • STEM-CELL-TRANSPLANTATION
  • ACUTE CORONARY SYNDROME
  • MOLECULAR-WEIGHT HEPARIN
  • PROPHYLACTIC PLATELET TRANSFUSIONS
  • RECURRENT VENOUS THROMBOEMBOLISM
  • ELEVATION MYOCARDIAL-INFARCTION
  • LOW-DOSE ASPIRIN
  • ATRIAL-FIBRILLATION
  • RISK-FACTORS
  • HEMATOLOGIC MALIGNANCIES

Cite this